Norges Bank’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-149,100
| Closed | -$2.69M | – | 1981 |
|
|
2023
Q2 | $2.69M | Hold |
149,100
| – | – | ﹤0.01% | 1837 |
|
|
2023
Q1 | $2.39M | Buy |
+149,100
| New | +$2.39M | ﹤0.01% | 1902 |
|
|
2022
Q2 | – | Sell |
-25,600
| Closed | -$562K | – | 2081 |
|
|
2022
Q1 | $562K | Sell |
25,600
-21,600
| -46% | -$474K | ﹤0.01% | 2094 |
|
|
2021
Q4 | $1.34M | Buy |
47,200
+25,600
| +119% | +$727K | ﹤0.01% | 2074 |
|
|
2021
Q3 | $455K | Sell |
21,600
-51,200
| -70% | -$1.08M | ﹤0.01% | 2210 |
|
|
2021
Q2 | $1.37M | Buy |
72,800
+39,200
| +117% | +$739K | ﹤0.01% | 2065 |
|
|
2021
Q1 | $513K | Buy |
+33,600
| New | +$513K | ﹤0.01% | 2087 |
|